News & Press

Jan 12, 2021

Lower-Profile WEB Intrasaccular Aneurysm Treatment Device Receives FDA Approval

The WEB™ Aneurysm Embolization System expands with a lower profile delivery system and new size configurations.

Dec 23, 2020

MicroVention, Inc. Files Trade Secret Lawsuit Against Balt USA, LLC

MicroVention, Inc., a U.S. based subsidiary of Terumo and leading global neurovascular company, announced today the filing of a second lawsuit against Balt USA, LLC and four former employees for trade secret misappropriation.

Sep 22, 2020

MicroVention-Terumo Announces New Leadership

The Company Appoints New President and CEO

Apr 21, 2020

Terumo Donates USD 2.4 Million in Cash and Products to Support COVID-19 Pandemic Relief Efforts Worldwide

Contributions include USD 1 million to the COVID-19 Solidarity Response Fund for WHO

Mar 27, 2020

MicroVention's Response to COVID-19

MicroVention has been closely following the daily developments and guidelines surrounding COVID-19, and our commitment remains true as we adjust to the current circumstances that all of us are facing during this challenging time.

Mar 13, 2020

MicroVention Expands Worldwide Innovation Center

Two years after MicroVention, Inc. relocated their Worldwide Innovation Center to 35 Enterprise, the neurovascular company is expanding within the Summit Office Campus to accommodate for their rapid growth.

Jan 08, 2020

MicroVention Announces FDA Premarket Approval of a New Flow Diverter for the Treatment of Brain Aneurysms

MicroVention, Inc., a U.S. based subsidiary of Terumo and a global neurovascular company announced the FDA Premarket Approval (PMA) for the FRED® (Flow Re-Direction Endoluminal Device) device for the treatment of brain aneurysms.

Home

Solutions

Aneurysm Therapy

Ischemic Stroke and Carotid Artery Disease

Neurovascular Malformations

Access Product Solutions

Products

Company

About Us

Executive Team

News

Events

Compliance

Careers

Overview

Job Openings

Contact